McNicoll Lewis & Vlak on Aastrom Biosciences' (ASTM) Phase II Results; Ixmyelocel-T Autologous Stem Cell Therapy Improves Heart Function

Go back to McNicoll Lewis & Vlak on Aastrom Biosciences' (ASTM) Phase II Results; Ixmyelocel-T Autologous Stem Cell Therapy Improves Heart Function